FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for olmesartan medoxomil and hydrochlorothiazide, a combination antihypertensive product from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Olmesartan Medoxomil and Hydrochlorothiazide (olmesartan medoxomil; hydrochlorothiazide)

Snippet

SUPPL AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)